Home › Funds › D. E. Shaw & Co › CCCC
D. E. Shaw & Co position in CCCC
C4 THERAPEUTICS INC · Health Care
Latest position (Q2 2026)1.74M sh
Reported value held$8.13M
Portfolio Weight0.00%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 9.88K | $442.00K | New |
| Q4 2021 | 25.73K | $829.00K | Add |
| Q2 2022 | 78.79K | $594.00K | New |
| Q3 2022 | 130.08K | $1.14M | Add |
| Q4 2022 | 85.96K | $507.17K | Reduce |
| Q1 2023 | 194.16K | $609.67K | Add |
| Q2 2023 | 519.18K | $1.43M | Add |
| Q3 2023 | 434.11K | $807.44K | Reduce |
| Q4 2023 | 243.64K | $1.38M | Reduce |
| Q1 2024 | 496.54K | $4.06M | Add |
| Q2 2024 | 356.21K | $1.65M | Reduce |
| Q3 2024 | 118.89K | $677.68K | Reduce |
| Q4 2024 | 76.48K | $275.32K | Reduce |
| Q1 2025 | 79.28K | $126.84K | Add |
| Q2 2025 | 89.47K | $127.95K | Add |
| Q3 2025 | 11.86K | $26.34K | Reduce |
| Q4 2025 | 52.88K | $101.00K | Add |
| Q1 2026 | 1.06M | $2.79M | Add |
| Q2 2026 | 1.74M | $8.13M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding CCCC
- Morgan Stanley 8.87M sh · $41.41M · Q2 2026
- BlackRock Inc 7.90M sh · $36.88M · Q2 2026
- JPMorgan Chase & Co 4.75M sh · $20.65M · Q2 2026
- Citadel Advisors 4.28M sh · $20.01M · Q2 2026
- Goldman Sachs Group 3.53M sh · $16.49M · Q2 2026
- Two Sigma Investments 3.47M sh · $16.20M · Q2 2026
- Bank of America Corp 2.66M sh · $12.41M · Q2 2026
- Geode Capital Management 2.52M sh · $11.78M · Q2 2026
- Vanguard Group 4.38M sh · $8.37M · Q4 2025
- Renaissance Technologies 1.19M sh · $5.56M · Q2 2026
- Northern Trust Corp 1.16M sh · $5.42M · Q2 2026